- $214.09m
- $154.65m
- $26.39m
- 47
- 36
- 10
- 21
Annual income statement for OmniAB, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 23.3 | 34.7 | 59.1 | 34.2 | 26.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 48.9 | 70.4 | 85.7 | 104 | 101 |
| Operating Profit | -25.6 | -35.6 | -26.6 | -69.4 | -74.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -23.7 | -34.4 | -26.1 | -64.4 | -71.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17.6 | -27 | -22.3 | -50.6 | -62 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -17.6 | -27 | -22.3 | -50.6 | -62 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -17.6 | -27 | -22.3 | -50.6 | -62 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.152 | -0.235 | -0.194 | -0.508 | -0.606 |